nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinblastine—TUBG1—forebrain—attention deficit hyperactivity disorder	0.0205	0.0315	CbGeAlD
Vinblastine—TUBD1—midbrain—attention deficit hyperactivity disorder	0.0161	0.0248	CbGeAlD
Vinblastine—TUBE1—midbrain—attention deficit hyperactivity disorder	0.0151	0.0232	CbGeAlD
Vinblastine—TUBG1—midbrain—attention deficit hyperactivity disorder	0.0135	0.0208	CbGeAlD
Vinblastine—TUBB8—nervous system—attention deficit hyperactivity disorder	0.0133	0.0204	CbGeAlD
Vinblastine—TUBB8—central nervous system—attention deficit hyperactivity disorder	0.0128	0.0196	CbGeAlD
Vinblastine—TUBD1—cerebellum—attention deficit hyperactivity disorder	0.0125	0.0192	CbGeAlD
Vinblastine—TUBE1—nervous system—attention deficit hyperactivity disorder	0.0124	0.0191	CbGeAlD
Vinblastine—TUBE1—central nervous system—attention deficit hyperactivity disorder	0.012	0.0184	CbGeAlD
Vinblastine—TUBA1A—forebrain—attention deficit hyperactivity disorder	0.0119	0.0182	CbGeAlD
Vinblastine—ABCC6—cardiovascular system—attention deficit hyperactivity disorder	0.0119	0.0182	CbGeAlD
Vinblastine—JUN—forebrain—attention deficit hyperactivity disorder	0.0118	0.018	CbGeAlD
Vinblastine—TUBE1—cerebellum—attention deficit hyperactivity disorder	0.0117	0.018	CbGeAlD
Vinblastine—TUBG1—nervous system—attention deficit hyperactivity disorder	0.0111	0.0171	CbGeAlD
Vinblastine—NR5A1—nervous system—attention deficit hyperactivity disorder	0.0109	0.0167	CbGeAlD
Vinblastine—TUBG1—central nervous system—attention deficit hyperactivity disorder	0.0107	0.0164	CbGeAlD
Vinblastine—TUBG1—cerebellum—attention deficit hyperactivity disorder	0.0105	0.0161	CbGeAlD
Vinblastine—NR5A1—central nervous system—attention deficit hyperactivity disorder	0.0105	0.016	CbGeAlD
Vinblastine—NR5A1—cerebellum—attention deficit hyperactivity disorder	0.0102	0.0157	CbGeAlD
Vinblastine—TUBB4A—forebrain—attention deficit hyperactivity disorder	0.0101	0.0156	CbGeAlD
Vinblastine—TUBB8—brain—attention deficit hyperactivity disorder	0.0101	0.0156	CbGeAlD
Vinblastine—TUBD1—brain—attention deficit hyperactivity disorder	0.0101	0.0156	CbGeAlD
Vinblastine—TUBA1A—cardiovascular system—attention deficit hyperactivity disorder	0.01	0.0154	CbGeAlD
Vinblastine—JUN—cardiovascular system—attention deficit hyperactivity disorder	0.00994	0.0153	CbGeAlD
Vinblastine—TUBB2B—forebrain—attention deficit hyperactivity disorder	0.0098	0.015	CbGeAlD
Vinblastine—TUBE1—brain—attention deficit hyperactivity disorder	0.0095	0.0146	CbGeAlD
Vinblastine—TUBB2A—forebrain—attention deficit hyperactivity disorder	0.00923	0.0142	CbGeAlD
Vinblastine—TUBB3—nervous system—attention deficit hyperactivity disorder	0.00905	0.0139	CbGeAlD
Vinblastine—TUBB1—nervous system—attention deficit hyperactivity disorder	0.00885	0.0136	CbGeAlD
Vinblastine—TUBB3—central nervous system—attention deficit hyperactivity disorder	0.00871	0.0134	CbGeAlD
Vinblastine—TUBB4A—cardiovascular system—attention deficit hyperactivity disorder	0.00858	0.0132	CbGeAlD
Vinblastine—TUBB1—central nervous system—attention deficit hyperactivity disorder	0.00852	0.0131	CbGeAlD
Vinblastine—TUBB3—cerebellum—attention deficit hyperactivity disorder	0.00852	0.0131	CbGeAlD
Vinblastine—TUBG1—brain—attention deficit hyperactivity disorder	0.00851	0.0131	CbGeAlD
Vinblastine—TUBB3—Parkin-Ubiquitin Proteasomal System pathway—STUB1—attention deficit hyperactivity disorder	0.00851	0.0244	CbGpPWpGaD
Vinblastine—NR5A1—brain—attention deficit hyperactivity disorder	0.0083	0.0127	CbGeAlD
Vinblastine—TUBB2A—Parkin-Ubiquitin Proteasomal System pathway—STUB1—attention deficit hyperactivity disorder	0.00824	0.0237	CbGpPWpGaD
Vinblastine—TUBB1—Parkin-Ubiquitin Proteasomal System pathway—STUB1—attention deficit hyperactivity disorder	0.00806	0.0231	CbGpPWpGaD
Vinblastine—TUBB4B—forebrain—attention deficit hyperactivity disorder	0.00791	0.0121	CbGeAlD
Vinblastine—TUBA1A—midbrain—attention deficit hyperactivity disorder	0.00784	0.012	CbGeAlD
Vinblastine—JUN—midbrain—attention deficit hyperactivity disorder	0.00776	0.0119	CbGeAlD
Vinblastine—TUBB6—cardiovascular system—attention deficit hyperactivity disorder	0.0077	0.0118	CbGeAlD
Vinblastine—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—COMT—attention deficit hyperactivity disorder	0.0075	0.0215	CbGpPWpGaD
Vinblastine—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—attention deficit hyperactivity disorder	0.00744	0.0214	CbGpPWpGaD
Vinblastine—TUBB2B—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.00743	0.0213	CbGpPWpGaD
Vinblastine—TUBB6—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.00743	0.0213	CbGpPWpGaD
Vinblastine—TUBB4A—Parkin-Ubiquitin Proteasomal System pathway—STUB1—attention deficit hyperactivity disorder	0.00723	0.0208	CbGpPWpGaD
Vinblastine—TUBB3—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.00718	0.0206	CbGpPWpGaD
Vinblastine—TUBB2A—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.00695	0.02	CbGpPWpGaD
Vinblastine—TUBB3—brain—attention deficit hyperactivity disorder	0.00692	0.0106	CbGeAlD
Vinblastine—TUBB1—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.0068	0.0195	CbGpPWpGaD
Vinblastine—TUBB1—brain—attention deficit hyperactivity disorder	0.00676	0.0104	CbGeAlD
Vinblastine—TUBB4A—midbrain—attention deficit hyperactivity disorder	0.0067	0.0103	CbGeAlD
Vinblastine—TUBB4B—cardiovascular system—attention deficit hyperactivity disorder	0.00669	0.0103	CbGeAlD
Vinblastine—TUBB4B—Parkin-Ubiquitin Proteasomal System pathway—STUB1—attention deficit hyperactivity disorder	0.00662	0.019	CbGpPWpGaD
Vinblastine—TUBB2B—midbrain—attention deficit hyperactivity disorder	0.00647	0.00994	CbGeAlD
Vinblastine—TUBA1A—nervous system—attention deficit hyperactivity disorder	0.00644	0.00989	CbGeAlD
Vinblastine—JUN—nervous system—attention deficit hyperactivity disorder	0.00638	0.00979	CbGeAlD
Vinblastine—TUBA1A—central nervous system—attention deficit hyperactivity disorder	0.0062	0.00952	CbGeAlD
Vinblastine—JUN—central nervous system—attention deficit hyperactivity disorder	0.00614	0.00943	CbGeAlD
Vinblastine—TUBB—midbrain—attention deficit hyperactivity disorder	0.00613	0.0094	CbGeAlD
Vinblastine—TUBB4A—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.0061	0.0175	CbGpPWpGaD
Vinblastine—TUBB2A—midbrain—attention deficit hyperactivity disorder	0.00609	0.00935	CbGeAlD
Vinblastine—TUBA1A—cerebellum—attention deficit hyperactivity disorder	0.00606	0.00931	CbGeAlD
Vinblastine—TUBB6—midbrain—attention deficit hyperactivity disorder	0.00601	0.00922	CbGeAlD
Vinblastine—JUN—cerebellum—attention deficit hyperactivity disorder	0.00601	0.00922	CbGeAlD
Vinblastine—TUBB4B—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.00558	0.016	CbGpPWpGaD
Vinblastine—TUBB4A—nervous system—attention deficit hyperactivity disorder	0.00551	0.00845	CbGeAlD
Vinblastine—TUBB2B—nervous system—attention deficit hyperactivity disorder	0.00532	0.00817	CbGeAlD
Vinblastine—TUBB4A—central nervous system—attention deficit hyperactivity disorder	0.0053	0.00814	CbGeAlD
Vinblastine—TUBB4B—midbrain—attention deficit hyperactivity disorder	0.00523	0.00802	CbGeAlD
Vinblastine—TUBB4A—cerebellum—attention deficit hyperactivity disorder	0.00518	0.00795	CbGeAlD
Vinblastine—SLC22A2—Norepinephrine Neurotransmitter Release Cycle—SNAP25—attention deficit hyperactivity disorder	0.00517	0.0148	CbGpPWpGaD
Vinblastine—TUBB2B—central nervous system—attention deficit hyperactivity disorder	0.00512	0.00786	CbGeAlD
Vinblastine—TUBB2A—nervous system—attention deficit hyperactivity disorder	0.00501	0.00769	CbGeAlD
Vinblastine—TUBB2B—cerebellum—attention deficit hyperactivity disorder	0.00501	0.00769	CbGeAlD
Vinblastine—TUBB6—nervous system—attention deficit hyperactivity disorder	0.00494	0.00758	CbGeAlD
Vinblastine—TUBA1A—brain—attention deficit hyperactivity disorder	0.00493	0.00756	CbGeAlD
Vinblastine—JUN—brain—attention deficit hyperactivity disorder	0.00488	0.00749	CbGeAlD
Vinblastine—TUBB2A—central nervous system—attention deficit hyperactivity disorder	0.00482	0.0074	CbGeAlD
Vinblastine—TUBB6—central nervous system—attention deficit hyperactivity disorder	0.00476	0.0073	CbGeAlD
Vinblastine—TUBB—cerebellum—attention deficit hyperactivity disorder	0.00474	0.00727	CbGeAlD
Vinblastine—TUBB2A—cerebellum—attention deficit hyperactivity disorder	0.00471	0.00723	CbGeAlD
Vinblastine—TUBB6—cerebellum—attention deficit hyperactivity disorder	0.00465	0.00714	CbGeAlD
Vinblastine—SLC22A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—attention deficit hyperactivity disorder	0.00441	0.0127	CbGpPWpGaD
Vinblastine—TUBB4B—nervous system—attention deficit hyperactivity disorder	0.0043	0.00659	CbGeAlD
Vinblastine—JUN—Androgen receptor signaling pathway—STUB1—attention deficit hyperactivity disorder	0.00422	0.0121	CbGpPWpGaD
Vinblastine—TUBB4A—brain—attention deficit hyperactivity disorder	0.00421	0.00646	CbGeAlD
Vinblastine—TUBB4B—central nervous system—attention deficit hyperactivity disorder	0.00414	0.00635	CbGeAlD
Vinblastine—TUBB2B—brain—attention deficit hyperactivity disorder	0.00407	0.00624	CbGeAlD
Vinblastine—TUBB4B—cerebellum—attention deficit hyperactivity disorder	0.00404	0.0062	CbGeAlD
Vinblastine—TUBG1—Cell Cycle—SYNE1—attention deficit hyperactivity disorder	0.00402	0.0115	CbGpPWpGaD
Vinblastine—SLC22A2—Norepinephrine Neurotransmitter Release Cycle—MAOA—attention deficit hyperactivity disorder	0.00389	0.0112	CbGpPWpGaD
Vinblastine—TUBB—brain—attention deficit hyperactivity disorder	0.00385	0.00591	CbGeAlD
Vinblastine—TUBB2A—brain—attention deficit hyperactivity disorder	0.00383	0.00588	CbGeAlD
Vinblastine—TUBB6—brain—attention deficit hyperactivity disorder	0.00378	0.0058	CbGeAlD
Vinblastine—ABCC6—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00344	0.00988	CbGpPWpGaD
Vinblastine—TUBB4B—brain—attention deficit hyperactivity disorder	0.00328	0.00504	CbGeAlD
Vinblastine—ABCC6—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00328	0.00943	CbGpPWpGaD
Vinblastine—JUN—Insulin Signaling—SNAP23—attention deficit hyperactivity disorder	0.00321	0.00921	CbGpPWpGaD
Vinblastine—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.0032	0.00491	CbGeAlD
Vinblastine—SLC22A2—Amine compound SLC transporters—SLC6A3—attention deficit hyperactivity disorder	0.00306	0.00879	CbGpPWpGaD
Vinblastine—ABCC1—cerebellum—attention deficit hyperactivity disorder	0.00288	0.00442	CbGeAlD
Vinblastine—NR5A1—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.00275	0.00791	CbGpPWpGaD
Vinblastine—SLC22A2—Neurotransmitter Release Cycle—SNAP25—attention deficit hyperactivity disorder	0.00263	0.00754	CbGpPWpGaD
Vinblastine—ABCC1—brain—attention deficit hyperactivity disorder	0.00234	0.00359	CbGeAlD
Vinblastine—TUBG1—G2/M Transition—EP300—attention deficit hyperactivity disorder	0.0023	0.00661	CbGpPWpGaD
Vinblastine—ABCB1—forebrain—attention deficit hyperactivity disorder	0.0023	0.00353	CbGeAlD
Vinblastine—TUBG1—Mitotic G2-G2/M phases—EP300—attention deficit hyperactivity disorder	0.00227	0.00652	CbGpPWpGaD
Vinblastine—TUBB2A—Signaling events mediated by HDAC Class III—EP300—attention deficit hyperactivity disorder	0.00203	0.00582	CbGpPWpGaD
Vinblastine—TUBA1A—Cell Cycle—SYNE1—attention deficit hyperactivity disorder	0.00201	0.00576	CbGpPWpGaD
Vinblastine—SLC22A2—Neurotransmitter Release Cycle—MAOA—attention deficit hyperactivity disorder	0.00198	0.00567	CbGpPWpGaD
Vinblastine—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.00195	0.00299	CbGeAlD
Vinblastine—NR5A1—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.00194	0.00557	CbGpPWpGaD
Vinblastine—TUBB6—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.0019	0.00546	CbGpPWpGaD
Vinblastine—TUBB2B—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.0019	0.00546	CbGpPWpGaD
Vinblastine—SLC22A2—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00184	0.00528	CbGpPWpGaD
Vinblastine—TUBB3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00184	0.00528	CbGpPWpGaD
Vinblastine—TUBB2B—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00181	0.00521	CbGpPWpGaD
Vinblastine—TUBB6—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00181	0.00521	CbGpPWpGaD
Vinblastine—TUBB2A—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00178	0.00511	CbGpPWpGaD
Vinblastine—NR5A1—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.00178	0.0051	CbGpPWpGaD
Vinblastine—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00176	0.00271	CbGeAlD
Vinblastine—TUBB3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00175	0.00503	CbGpPWpGaD
Vinblastine—TUBB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00174	0.005	CbGpPWpGaD
Vinblastine—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.00174	0.00266	CbGeAlD
Vinblastine—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.0017	0.00261	CbGeAlD
Vinblastine—TUBB2A—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.0017	0.00487	CbGpPWpGaD
Vinblastine—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.00167	0.00257	CbGeAlD
Vinblastine—TUBB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00166	0.00477	CbGpPWpGaD
Vinblastine—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.00163	0.00251	CbGeAlD
Vinblastine—JUN—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.0016	0.00459	CbGpPWpGaD
Vinblastine—TUBB—Cell Cycle—SYNE1—attention deficit hyperactivity disorder	0.0016	0.00459	CbGpPWpGaD
Vinblastine—JUN—Pre-NOTCH Transcription and Translation—EP300—attention deficit hyperactivity disorder	0.0016	0.00458	CbGpPWpGaD
Vinblastine—SLC22A2—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00156	0.00449	CbGpPWpGaD
Vinblastine—TUBB4A—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00156	0.00449	CbGpPWpGaD
Vinblastine—TUBA1A—p73 transcription factor network—EP300—attention deficit hyperactivity disorder	0.00153	0.0044	CbGpPWpGaD
Vinblastine—ABCB1—midbrain—attention deficit hyperactivity disorder	0.00152	0.00233	CbGeAlD
Vinblastine—TUBB4A—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00149	0.00428	CbGpPWpGaD
Vinblastine—TUBB4B—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00143	0.0041	CbGpPWpGaD
Vinblastine—SLC22A2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00141	0.00405	CbGpPWpGaD
Vinblastine—JUN—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.00137	0.00395	CbGpPWpGaD
Vinblastine—CYP2D6—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00137	0.00393	CbGpPWpGaD
Vinblastine—TUBB4B—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00136	0.00391	CbGpPWpGaD
Vinblastine—CYP2D6—brain—attention deficit hyperactivity disorder	0.00133	0.00204	CbGeAlD
Vinblastine—TUBB4A—Cell Cycle—SYNE1—attention deficit hyperactivity disorder	0.00132	0.0038	CbGpPWpGaD
Vinblastine—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00132	0.00379	CbGpPWpGaD
Vinblastine—JUN—Validated transcriptional targets of AP1 family members Fra1 and Fra2—EP300—attention deficit hyperactivity disorder	0.00131	0.00377	CbGpPWpGaD
Vinblastine—JUN—Circadian rythm related genes—TPH2—attention deficit hyperactivity disorder	0.00131	0.00375	CbGpPWpGaD
Vinblastine—JUN—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.00128	0.00367	CbGpPWpGaD
Vinblastine—JUN—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.00128	0.00367	CbGpPWpGaD
Vinblastine—NR5A1—Gene Expression—POLR3A—attention deficit hyperactivity disorder	0.00127	0.00364	CbGpPWpGaD
Vinblastine—JUN—Insulin Signaling—SNAP25—attention deficit hyperactivity disorder	0.00125	0.0036	CbGpPWpGaD
Vinblastine—ABCB1—nervous system—attention deficit hyperactivity disorder	0.00125	0.00192	CbGeAlD
Vinblastine—TUBB4B—Cell Cycle—SYNE1—attention deficit hyperactivity disorder	0.00121	0.00348	CbGpPWpGaD
Vinblastine—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.0012	0.00185	CbGeAlD
Vinblastine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.0012	0.00344	CbGpPWpGaD
Vinblastine—ABCC6—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.0012	0.00344	CbGpPWpGaD
Vinblastine—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.00118	0.0018	CbGeAlD
Vinblastine—TUBA1A—G2/M Transition—EP300—attention deficit hyperactivity disorder	0.00115	0.0033	CbGpPWpGaD
Vinblastine—JUN—FOXA1 transcription factor network—EP300—attention deficit hyperactivity disorder	0.00114	0.00328	CbGpPWpGaD
Vinblastine—TUBA1A—Mitotic G2-G2/M phases—EP300—attention deficit hyperactivity disorder	0.00113	0.00326	CbGpPWpGaD
Vinblastine—ABCC2—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.00113	0.00323	CbGpPWpGaD
Vinblastine—JUN—Pre-NOTCH Expression and Processing—EP300—attention deficit hyperactivity disorder	0.00112	0.00322	CbGpPWpGaD
Vinblastine—JUN—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.0011	0.00317	CbGpPWpGaD
Vinblastine—JUN—Circadian rythm related genes—SLC6A4—attention deficit hyperactivity disorder	0.00104	0.003	CbGpPWpGaD
Vinblastine—JUN—Circadian rythm related genes—DRD1—attention deficit hyperactivity disorder	0.00104	0.003	CbGpPWpGaD
Vinblastine—JUN—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.00101	0.0029	CbGpPWpGaD
Vinblastine—ABCC2—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.001	0.00288	CbGpPWpGaD
Vinblastine—JUN—BDNF signaling pathway—BDNF—attention deficit hyperactivity disorder	0.000989	0.00284	CbGpPWpGaD
Vinblastine—JUN—Regulation of Androgen receptor activity—EP300—attention deficit hyperactivity disorder	0.000985	0.00283	CbGpPWpGaD
Vinblastine—JUN—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.000981	0.00282	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—MB21D1—attention deficit hyperactivity disorder	0.000978	0.00281	CbGpPWpGaD
Vinblastine—JUN—TGF-beta Receptor Signaling—EP300—attention deficit hyperactivity disorder	0.00097	0.00279	CbGpPWpGaD
Vinblastine—JUN—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.000962	0.00276	CbGpPWpGaD
Vinblastine—ABCB1—brain—attention deficit hyperactivity disorder	0.000955	0.00147	CbGeAlD
Vinblastine—SLC22A2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000942	0.00271	CbGpPWpGaD
Vinblastine—JUN—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000928	0.00266	CbGpPWpGaD
Vinblastine—ABCC2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000924	0.00265	CbGpPWpGaD
Vinblastine—TUBB—G2/M Transition—EP300—attention deficit hyperactivity disorder	0.000917	0.00263	CbGpPWpGaD
Vinblastine—JUN—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.000914	0.00262	CbGpPWpGaD
Vinblastine—ABCC1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000913	0.00262	CbGpPWpGaD
Vinblastine—TUBB—Mitotic G2-G2/M phases—EP300—attention deficit hyperactivity disorder	0.000904	0.0026	CbGpPWpGaD
Vinblastine—JUN—ATF-2 transcription factor network—EP300—attention deficit hyperactivity disorder	0.000904	0.0026	CbGpPWpGaD
Vinblastine—ABCC2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000881	0.00253	CbGpPWpGaD
Vinblastine—JUN—MAPK Signaling Pathway—BDNF—attention deficit hyperactivity disorder	0.000874	0.00251	CbGpPWpGaD
Vinblastine—ABCC1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000871	0.0025	CbGpPWpGaD
Vinblastine—JUN—Validated nuclear estrogen receptor alpha network—EP300—attention deficit hyperactivity disorder	0.000847	0.00243	CbGpPWpGaD
Vinblastine—JUN—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000827	0.00237	CbGpPWpGaD
Vinblastine—JUN—Regulation of retinoblastoma protein—EP300—attention deficit hyperactivity disorder	0.000827	0.00237	CbGpPWpGaD
Vinblastine—SLC22A2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00081	0.00233	CbGpPWpGaD
Vinblastine—SLC22A2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000795	0.00228	CbGpPWpGaD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000789	0.00227	CbGpPWpGaD
Vinblastine—JUN—AP-1 transcription factor network—EP300—attention deficit hyperactivity disorder	0.000789	0.00226	CbGpPWpGaD
Vinblastine—JUN—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000784	0.00225	CbGpPWpGaD
Vinblastine—TUBB4A—G2/M Transition—EP300—attention deficit hyperactivity disorder	0.00076	0.00218	CbGpPWpGaD
Vinblastine—SLC22A2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000758	0.00218	CbGpPWpGaD
Vinblastine—SLC22A2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000753	0.00216	CbGpPWpGaD
Vinblastine—TUBB4A—Mitotic G2-G2/M phases—EP300—attention deficit hyperactivity disorder	0.000749	0.00215	CbGpPWpGaD
Vinblastine—TUBG1—Cell Cycle, Mitotic—EP300—attention deficit hyperactivity disorder	0.000733	0.0021	CbGpPWpGaD
Vinblastine—SLC22A2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000722	0.00207	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—POLR3A—attention deficit hyperactivity disorder	0.000717	0.00206	CbGpPWpGaD
Vinblastine—JUN—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—attention deficit hyperactivity disorder	0.000709	0.00203	CbGpPWpGaD
Vinblastine—JUN—Regulation of nuclear SMAD2/3 signaling—EP300—attention deficit hyperactivity disorder	0.000702	0.00201	CbGpPWpGaD
Vinblastine—TUBB4B—G2/M Transition—EP300—attention deficit hyperactivity disorder	0.000695	0.002	CbGpPWpGaD
Vinblastine—JUN—Glucocorticoid receptor regulatory network—EP300—attention deficit hyperactivity disorder	0.000695	0.00199	CbGpPWpGaD
Vinblastine—TUBB4B—Mitotic G2-G2/M phases—EP300—attention deficit hyperactivity disorder	0.000685	0.00197	CbGpPWpGaD
Vinblastine—SLC22A2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000671	0.00193	CbGpPWpGaD
Vinblastine—TUBB6—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000662	0.0019	CbGpPWpGaD
Vinblastine—TUBB2B—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000662	0.0019	CbGpPWpGaD
Vinblastine—TUBG1—Cell Cycle—EP300—attention deficit hyperactivity disorder	0.000655	0.00188	CbGpPWpGaD
Vinblastine—JUN—Androgen receptor signaling pathway—EP300—attention deficit hyperactivity disorder	0.000651	0.00187	CbGpPWpGaD
Vinblastine—TUBB3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000639	0.00184	CbGpPWpGaD
Vinblastine—SLC22A2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000621	0.00178	CbGpPWpGaD
Vinblastine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00062	0.00178	CbGpPWpGaD
Vinblastine—TUBB2A—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000619	0.00178	CbGpPWpGaD
Vinblastine—TUBB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000606	0.00174	CbGpPWpGaD
Vinblastine—JUN—Wnt Signaling Pathway and Pluripotency—EP300—attention deficit hyperactivity disorder	0.000583	0.00168	CbGpPWpGaD
Vinblastine—SLC22A2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000577	0.00166	CbGpPWpGaD
Vinblastine—SLC22A2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000571	0.00164	CbGpPWpGaD
Vinblastine—JUN—Immune System—MB21D1—attention deficit hyperactivity disorder	0.000569	0.00163	CbGpPWpGaD
Vinblastine—SLC22A2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000567	0.00163	CbGpPWpGaD
Vinblastine—JUN—Signaling by NOTCH—EP300—attention deficit hyperactivity disorder	0.000553	0.00159	CbGpPWpGaD
Vinblastine—JUN—Immune System—STUB1—attention deficit hyperactivity disorder	0.000551	0.00158	CbGpPWpGaD
Vinblastine—SLC22A2—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000544	0.00156	CbGpPWpGaD
Vinblastine—TUBB4A—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000544	0.00156	CbGpPWpGaD
Vinblastine—SLC22A2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000514	0.00148	CbGpPWpGaD
Vinblastine—NR5A1—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000504	0.00145	CbGpPWpGaD
Vinblastine—TUBB4B—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000497	0.00143	CbGpPWpGaD
Vinblastine—JUN—TGF-beta Signaling Pathway—EP300—attention deficit hyperactivity disorder	0.000475	0.00136	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000457	0.00131	CbGpPWpGaD
Vinblastine—JUN—Direct p53 effectors—EP300—attention deficit hyperactivity disorder	0.000453	0.0013	CbGpPWpGaD
Vinblastine—SLC22A2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000437	0.00126	CbGpPWpGaD
Vinblastine—SLC22A2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000434	0.00125	CbGpPWpGaD
Vinblastine—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000434	0.00125	CbGpPWpGaD
Vinblastine—JUN—Integrated Breast Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000426	0.00122	CbGpPWpGaD
Vinblastine—ABCC1—Disease—STUB1—attention deficit hyperactivity disorder	0.00042	0.00121	CbGpPWpGaD
Vinblastine—JUN—Immune System—POLR3A—attention deficit hyperactivity disorder	0.000418	0.0012	CbGpPWpGaD
Vinblastine—JUN—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000415	0.00119	CbGpPWpGaD
Vinblastine—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000414	0.00119	CbGpPWpGaD
Vinblastine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000405	0.00116	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000403	0.00116	CbGpPWpGaD
Vinblastine—TUBA1A—Cell Cycle, Mitotic—EP300—attention deficit hyperactivity disorder	0.000366	0.00105	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000356	0.00102	CbGpPWpGaD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000353	0.00101	CbGpPWpGaD
Vinblastine—JUN—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.000339	0.000974	CbGpPWpGaD
Vinblastine—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000332	0.000952	CbGpPWpGaD
Vinblastine—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000329	0.000945	CbGpPWpGaD
Vinblastine—TUBA1A—Cell Cycle—EP300—attention deficit hyperactivity disorder	0.000327	0.00094	CbGpPWpGaD
Vinblastine—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000327	0.000939	CbGpPWpGaD
Vinblastine—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000325	0.000932	CbGpPWpGaD
Vinblastine—ABCC2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000321	0.000923	CbGpPWpGaD
Vinblastine—ABCC1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000318	0.000912	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.00031	0.00089	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000306	0.000879	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000302	0.000868	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.0003	0.000861	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000294	0.000845	CbGpPWpGaD
Vinblastine—TUBB—Cell Cycle, Mitotic—EP300—attention deficit hyperactivity disorder	0.000292	0.000837	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000278	0.000798	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000278	0.000798	CbGpPWpGaD
Vinblastine—SLC22A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000277	0.000794	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000273	0.000785	CbGpPWpGaD
Vinblastine—JUN—Cellular responses to stress—EP300—attention deficit hyperactivity disorder	0.000273	0.000783	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000263	0.000756	CbGpPWpGaD
Vinblastine—TUBB—Cell Cycle—EP300—attention deficit hyperactivity disorder	0.000261	0.000749	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000254	0.00073	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle, Mitotic—EP300—attention deficit hyperactivity disorder	0.000242	0.000694	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000222	0.000638	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle, Mitotic—EP300—attention deficit hyperactivity disorder	0.000221	0.000635	CbGpPWpGaD
Vinblastine—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000217	0.000622	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle—EP300—attention deficit hyperactivity disorder	0.000216	0.00062	CbGpPWpGaD
Vinblastine—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000215	0.000618	CbGpPWpGaD
Vinblastine—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000214	0.000614	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000212	0.000607	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000209	0.000599	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000209	0.000599	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000208	0.000597	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000205	0.00059	CbGpPWpGaD
Vinblastine—ABCC1—Disease—SNAP25—attention deficit hyperactivity disorder	0.000199	0.000572	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle—EP300—attention deficit hyperactivity disorder	0.000198	0.000567	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000191	0.000548	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000182	0.000522	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000182	0.000522	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000182	0.000522	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000179	0.000514	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000169	0.000485	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—COMT—attention deficit hyperactivity disorder	0.000168	0.000483	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000167	0.00048	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000167	0.000479	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000166	0.000477	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000164	0.00047	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000162	0.000465	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000161	0.000462	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000159	0.000456	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000159	0.000456	CbGpPWpGaD
Vinblastine—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000151	0.000434	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000148	0.000425	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000146	0.000419	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000145	0.000417	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000144	0.000413	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000139	0.000398	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000138	0.000397	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000136	0.000389	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000126	0.000363	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000126	0.000361	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000122	0.00035	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—COMT—attention deficit hyperactivity disorder	0.00011	0.000316	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000109	0.000314	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000104	0.000298	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	9.93e-05	0.000285	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	9.93e-05	0.000285	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	9.77e-05	0.000281	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	9.36e-05	0.000269	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	9.36e-05	0.000269	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	9.21e-05	0.000264	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.08e-05	0.000261	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	8.87e-05	0.000255	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	8.56e-05	0.000246	CbGpPWpGaD
Vinblastine—JUN—Immune System—EP300—attention deficit hyperactivity disorder	8.5e-05	0.000244	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.94e-05	0.000228	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.56e-05	0.000217	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.48e-05	0.000215	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—EP300—attention deficit hyperactivity disorder	7.22e-05	0.000207	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.12e-05	0.000204	CbGpPWpGaD
Vinblastine—ABCC1—Disease—EP300—attention deficit hyperactivity disorder	6.48e-05	0.000186	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	6.12e-05	0.000176	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	6.12e-05	0.000176	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	6.02e-05	0.000173	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	6.02e-05	0.000173	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	5.98e-05	0.000172	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	5.67e-05	0.000163	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	5.63e-05	0.000162	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	5.6e-05	0.000161	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.49e-05	0.000158	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—EP300—attention deficit hyperactivity disorder	5.42e-05	0.000156	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.89e-05	0.00014	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—EP300—attention deficit hyperactivity disorder	4.72e-05	0.000136	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	4.66e-05	0.000134	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	3.71e-05	0.000106	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	3.68e-05	0.000106	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	2.58e-05	7.41e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	2.43e-05	6.98e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	1.59e-05	4.56e-05	CbGpPWpGaD
